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Barrier Abnormality Due to Ceramide Deficiency
Leads to Psoriasiform Inflammation in a Mouse Model
Kimiko Nakajima1, Mika Terao2, Mikiro Takaishi1, Sayo Kataoka3, Naoko Goto-Inoue4,5, Mitsutoshi Setou5,
Kyoji Horie6, Fumiko Sakamoto7, Masaaki Ito7, Hiroaki Azukizawa2, Shun Kitaba2, Hiroyuki Murota2,
Satoshi Itami8, Ichiro Katayama2, Junji Takeda6 and Shigetoshi Sano1
It has been recognized that ceramides are decreased in the epidermis of patients with psoriasis and atopic
dermatitis. Here, we generated Sptlc2 (serine palmitoyltransferase long-chain base subunit 2)-targeted mice
(SPT-cKO mice), thereby knocking out serine palmitoyltransferase (SPT), the critical enzyme for ceramide
biosynthesis, in keratinocytes. SPT-cKO mice showed decreased ceramide levels in the epidermis, which impaired
water-holding capacity and barrier function. From 2 weeks of age, they developed skin lesions with histological
aberrations including hyperkeratosis, acanthosis, loss of the granular layer, and inflammatory cell infiltrates.
Epidermal Langerhans cells showed persistent activation and enhanced migration to lymph nodes. Skin lesions
showed upregulation of psoriasis-associated genes, such as IL-17A, IL-17F, IL-22, S100A8, S100A9, and b-defensins.
In the skin lesions and draining lymph nodes, there were increased numbers of gd T cells that produced IL-17
(gd-17 cells), most of which also produced IL-22, as do Th17 cells. Furthermore, IL-23-producing CD11cþ cells
were observed in the lesions. In vivo treatment of SPT-cKO mice with an anti-IL-12/23p40 antibody ameliorated
the skin lesions and reduced the numbers of gd-17 cells. Therefore, we conclude that a ceramide deficiency
in the epidermis leads to psoriasis-like lesions in mice, probably mediated by IL-23-dependent IL-22-producing
gd-17 cells.
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INTRODUCTION
Inflammatory skin diseases are often associated with disrup-
tion of the skin barrier function, although the cause and effect
relationship is complex. The discovery of loss-of-function
mutations in the filaggrin (FLG) gene in patients with atopic
dermatitis (AD) revealed that disruption of the skin barrier is
the primary cause of the disease (Palmer et al., 2006; Irvine
et al., 2011). Similar to AD, the barrier function is altered
in psoriasis although it remains unknown whether the abnor-
mality of barrier function is a primary cause. Koebner pheno-
menon suggests that epidermal injury initiates the formation of
psoriatic lesions. It is well known that occlusion (barrier
restoration) reverses psoriatic lesions. Furthermore, multiple
types of chronic barrier insults in experimental animals
produce inflammation: for example, repeated tape stripping
(TS); repeated applications of statins or lipid-secretion inhibi-
tors; and essential fatty acid deficiency diet (Wood et al.,
1992; Feingold, 2007). Recent discoveries of the epidermal
genes as psoriasis risk factors suggest the barrier abnormalities
underlie the pathogenesis of psoriasis (Bergboer et al., 2012).
Among psoriasis model mice, some of them exhibit barrier
dysfunction that links to altered immune response (Sano et al.,
2005; Hwang et al. 2012).
Stratum corneum (SC) lipids are derived from the contents
of lamellar bodies (LBs) in granular cells and comprise a
mixture of sphingolipids, cholesterol, and fatty acids, arranged
as intercellular membrane bilayers that are required for the
epidermal permeability barrier (Elias and Menon, 1991;
Feingold, 2007). Ceramides play an essential role in the
permeability barrier of the intercellular space and for the
water retention of the SC (Elias and Menon, 1991). De novo
synthesis of ceramides starts with a condensation of serine
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and palmitoyl-CoA by serine palmitoyltranferase (SPT), the
rate-limiting enzyme, which is ubiquitously found, including
in the epidermis (Holleran et al., 1990).
It has been reported that ceramides are significantly
decreased in the epidermis of patients with psoriasis, as
well as AD (Melnik et al., 1988; Holleran et al., 1991;
Imokawa et al., 1991; Motta et al., 1993, 1994; Alessandrini
et al., 2004). SPT expression is significantly reduced in
psoriatic lesions compared with uninvolved skin (Hong et al.,
2007). To investigate whether decrease of ceramide levels in
the epidermis would lead to an inflammatory skin disease,
we generated keratinocyte-specific SPT gene–targeted mice.
The present study reveals a pathogenic link between the
primary barrier disruption due to ceramide deficiency and
immune responses that lead to psoriasis-like skin inflammation.
RESULTS
Decrease of ceramide levels in psoriatic epidermis and the
generation of SPT-cKO mice
As previously recognized, psoriatic epidermis showed
decreased ceramide levels compared with normal epidermis
by immunostaining (Figure 1a). Correspondingly, the water-
holding capacity and barrier function of the epidermis were
impaired in psoriatic lesions compared with the uninvolved
skin of patients with chronic, plaque-type psoriasis (psoriasis
vulgaris) and control healthy skin (Figure 1b and c). As a
previous study demonstrated that SPT is decreased in psoriatic
lesions (Hong et al., 2007), the decrease in ceramides may be,
at least in part, due to the decrease in SPT level. As the Sptlc2
(serine palmitoyltransferase long-chain base subunit (2))
protein confers the catalytic activity of SPT (Dickson et al.,
2000), Cre/loxP-mediated targeting of the Sptlc2 gene was
undertaken under control of the K5 promoter to generate
keratinocyte-specific SPT-targeted mice (Supplementary Figure
S1a online; Tarutani et al., 1997; Ohta et al., 2009). Southern
blot analysis and reverse transciptase (RT–PCR) verified
the keratinocyte-specific targeting of the Sptlc2 gene
(Supplementary Figure S1b and c online). Newborn K5-Cre:
Sptlc2flox/flox (SPT-cKO) mice presented with generalized
xerosis (Figure 1d). However, their epidermis did not show
any alteration in the histology or expression of K5, K1, K6,
involucrin, filaggrin, or loricrin (Supplementary Figure S2
online). The water-holding capacity of SPT-cKO mice was
reduced to 35% of the level found in wild-type (WT) mice
(Po0.001, Figure 1e), whereas transepidermal water loss
(TEWL) was unexpectedly normal at birth (Figures 2b and
3a). A novel method of imaging mass spectrometric analysis
(Goto-Inoue et al., 2012), which allowed us to identify
ceramide species and their distribution, demonstrated a
marked reduction of ceramide (Cer, d18:1/C24:1 at m/z
630.4) and ceramide-1-phosphate (Cer-1-P, d18:1/C18:0 at
m/z 646.4) in the epidermis of footpad skin from SPT-cKO
mice compared with those from WT mice (Figure 1f and g).
Taken collectively, keratinocyte-specific SPT deficiency leads
to a marked reduction of ceramide levels in the epidermis and
constitutional impairment of hydration, although it does not
affect skin barrier function or expression of epidermal differ-
entiation molecules at birth.
SPT deficiency in keratinocytes impairs barrier recovery
after TS
Electron microscopic examination revealed that LBs in new-
born SPT-cKO mice showed a normal, disc-like appearance,
but those in SPT-cKO mice at postnatal day 14 (PD14) had
abnormal globular inclusions (Figure 2a). This result suggested
that the defect in ceramide biosynthesis affected LB structure
over time. Furthermore, the abnormal contents in LBs were
similar to those with topical SPT inhibitor application
(Holleran et al., 1991). Previous studies demonstrated that
SPT in the epidermis is required for barrier restoration
(Holleran et al., 1991, 1995). To verify this, the process of
barrier recovery after TS of the skin was examined in SPT-cKO
mice. As expected, SPT-cKO mice at PD3 demonstrated a
significant elevation of TEWL at 2.5 h (P¼0.0029) and at 6 h
(P¼ 0.0002) after TS, indicating a delay in barrier restoration
in SPT-cKO mice compared with WT (Figure 2b). Electron
microscopic examination at 6 h after TS revealed a delay in LB
secretion into the extracellular space after TS, whereas in WT
mice the intercellular lamellar units were regenerated
(Figure 2c). These results suggest that LB secretion is depen-
dent on SPT-dependent de novo synthesis of ceramides during
the immediate barrier recovery. As ceramides could be
provided from diet, for example, the barrier was restored by
24 h (Figure 2b).
Development of psoriasis-like skin lesions in SPT-cKO mice
after 2 weeks of age
Although newborn SPT-cKO mice under steady state harbored
an intact barrier function, it became disrupted and worsened
from 2 weeks of age onward (Figure 3a). Correspondingly,
electron microscopic examination demonstrated that numbers
of LBs within keratinocytes in the granular layer significantly
declined in SPT-cKO mice from 2 weeks onward (Figure 3b).
After PD7, they showed growth retardation, sparse hair, and
scales over their body (Figure 3c, left panel). SPT-cKO mice
then developed alopecia in the periocular and upper back
areas, and were covered with thick scales (Figure 3c, middle
panel). From 3 weeks of age, the lesions deteriorated with
alopecia, hyperkeratosis, and generalized erythema (Figure 3c,
right panel). Most, if not all, SPT-cKO mice died by PD25. The
skin histology of SPT-cKO mice from 2 weeks of age and older
demonstrated a marked acanthosis, hyperkeratosis, loss of the
granular layer, and cell infiltrates in the dermis (Figure 3d,
bottom panel). Similar to psoriasis, there were a number of
neutrophil infiltrates in the upper dermis and sub-to-intracor-
neal neutrophil accumulation resembling ‘‘the Munro’s micro-
abscess’’ (Supplementary Figure S3 online). Furthermore,
similar to psoriatic lesions, K6 expression was observed in
the whole layer of acanthotic epidermis in SPT-cKO mice
(Figure 3e, bottom panel, Supplementary Figure S4b online),
suggestive of an inflamed and hyperproliferative condition of
the epidermis, whereas WT mice showed K6 only at the outer
root sheath of hair follicles (Figure 3e, top panel). Interfolli-
cular epidermal K6 was observed as early as PD6 in SPT-cKO,
in which acanthosis did not yet develop, suggesting that
ceramide deficiency might upregulate inflammatory signals
(Supplementary Figure S4a online). On the other hand,
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distribution and expressions of cornified envelope proteins
including involucrin, filaggrin, and loricrin remained intact in
SPT-cKO mice over time with age (Supplementary Figure S4b
online). Electron microscopic examination revealed a number
of lipid inclusions in the SC, and vesicles in the stratum
granulosum (SG) layer (Supplementary Figure S5a and b
online). Notably, there were abnormal LBs and malformation
of lamellar structures (Supplementary Figure S5c online).
These changes resemble the ultrastructural alterations in active
plaque psoriasis, in which corneocytes retain cytosolic LBs,
Normal
140 ns ns
*** ***
†† ††
120
80
60
40
20
No
rm
al
Inv
olv
ed
Un
inv
olv
ed
No
rm
al
Inv
olv
ed
Un
inv
olv
ed
40
30
50
50
20
10
25
35
45
15
5
0
0
0
40
30
50
20
10
25
35
45
15
5
0
WT
**
Cer-1-PCer
WT
WT
cKO
cKO
WT cKO
***
100
100
200
150
Co
nd
uc
ta
nc
e 
(μS
)
Co
nd
uc
ta
nc
e 
(μS
)
TE
W
L 
(g·
h–
1 m
–
2 )
Ar
bi
tra
ry
 u
ni
ts
 o
f c
er
a
m
id
es
Psoriasis
cKO cKO
e
e
50 μm Psoriasis Psoriasis
Figure 1. Decreased ceramides in the epidermis of psoriasis patients and the phenotype of newborn SPT-cKO mice. (a) Skin sections from a healthy subject
(top) and a psoriasis patient (bottom) were stained with an anti-ceramide antibody. Ceramide levels were decreased in the thickened epidermis of the psoriasis
patient compared with the normal healthy epidermis. Representative images are shown from three independent experiments. e, epidermis. Bar¼ 50mm.
(b, c) Involved skins (n¼ 9) from patients with chronic, plaque psoriasis (psoriasis vulgaris) show impaired water-holding capacity (b, evaluation by electrical
conductance) and permeability barrier function (c, evaluation by transepidermal water loss) compared with uninvolved skins (n¼ 9) and normal skins from healthy
donors (n¼9). Horizontal bars represent means. Statistical significance is indicated by ***Po0.001. ns, not significant. Unpaired Student’s t-test, and by zzPo0.01,
Wilcoxon t-test. (d) Gross appearance of newborn wild-type (WT) and SPT-cKO (cKO) mice. (e) Decreased water retention in newborn SPT-cKO mice (black bar)
compared with WT mice (white bar). Data show the mean conductance (mS)±SE of three experiments with four to six mice each. ***Po0.001. Unpaired Student’s
t-test. (f) Imaging mass spectrometry (IMS) analysis using footpad skin sections of SPT-cKO and WT mice at postnatal day (PD)3. Ion images of the epidermis
of SPT-cKO mice revealed that ceramide (Cer, d18:1/C24:1 at m/z 630.4) and ceramide-1-phosphate (Cer-1-P, d18:1/C18:0 at m/z 646.4) were markedly
decreased compared with WT mice. (g) Quantification of IMS signal intensity using ImageJ shows a significant decrease in the ceramide signal in SPT-cKO
epidermis (black bar) compared with WT (white bar). Graph shows arbitrary units (mean±SE). n¼ 3. **Po0.01. Unpaired Student’s t-test.
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lipid droplets, and extracellular domains largely devoid of
lamellae (Ghadially et al., 1996). As the K5 promoter is active
in the upper digestive tract as well, hyperkeratosis was also
observed in epithelia of the esophagus (data not shown) and
the forestomach in SPT-cKO mice, but not in WT mice
(Figure 3f, bottom versus top panel). Immunohistological study
revealed no SPT expression in the epidermis and the outer root
sheath in SPT-cKO, (Figure 3g, left bottom panel), whereas
SPT was detected in the epidermis and outer root sheath of
WT mice (Figure 3g, left top panel). This was because the
conditional gene targeting was undertaken under the K5
promoter. It should be noted that dermal inflammatory cells
showed a high SPT expression in SPT-cKO mice (asterisk in
Figure 3g).
Activation and enhanced migration of Langerhans cells to lymph
nodes in SPT-cKO mice
Staining of epidermal sheets taken from SPT-cKO mice at
PD18 with anti-CD207 (langerin) showed that Langerhans
cells (LCs) appeared to be somewhat spherical in morphol-
ogy, with fewer dendrites compared with those of WT mice
(Supplementary Figure S6a online). Interestingly, immunos-
taining with anti-CD207 (langerin) revealed that LCs in SPT-
cKO mice had elongated dendrites upward beneath the SC
(Supplementary Figure S6b online, right panels), suggesting
that LC activation occurred in response to the barrier
disruption. In contrast, LCs in WT mice resided in the basal
layer of the epidermis with horizontally spreading dendrites
(Supplementary Figure S6b online, left bottom panel). Those
data support the previous finding that LC activation by TS
leads to dendrite elongation that penetrates tight junctions
to capture external antigens (Kubo et al., 2009). FACS analy-
sis of isolated LCs from the skin of SPT-cKO mice showed
the upregulation of CD80 and CD86 (data not shown),
suggesting LC activation. Furthermore, the skin-draining
lymph nodes (SDLNs) of SPT-cKO mice showed increased
numbers of CD40highCD11cint cells (Supplementary Figure
S6c online), suggesting enhanced LC migration from the
epidermis (Ruedl et al., 2000). However, there was no
increase in numbers of resident DC population identified
as CD40intCD11chigt cells (Supplementary Figure S6c
online). Staining with anti-langerin of the CD40highCD11cint
population revealed large increases in the numbers of
langerinþ cells in the SDLNs of SPT-cKO mice compared
with WT mice (Supplementary Figure S6d and S6e online).
This finding was consistent, in part, with previous reports
showing that mechanical disruption of the skin barrier by TS
leads to LC activation and migration from the skin to SDLNs
(Holzmann et al., 2004; Strid et al., 2011).
Expansion of IL-17-producing cd T cells in SPT-cKO mice
Quantitative RT–PCR analysis of the skin lesions at PD18
revealed upregulation of psoriatic-associated genes, including
Th17 cytokines such as IL-17A, IL-17F, IL-22, S100A8,
S100A9, and b-defensins 3 and 4 (Figure 4a). In addition to
the histopathological changes, therefore, gene expression
profiles of diseased SPT-cKO mice closely resembled psor-
iasis. As found in the skin lesions, SDLN cells in SPT-cKO
mice showed upregulation of mRNA transcript levels of IL-
17A, IL-17F, and IL-22 (Figure 4b). FACS analysis of SDLNs
from SPT-cKO mice showed that not only IL-17-producing
CD4þ cells (Th17) but also CD4-CD8- gd T cells (gd-17) were
increased (Figure 4c and d; data not shown).In addition, there
was gd-17 cell expansion in the skin lesions (Figure 4e). In
SPT-cKO mice at PD11, the increase in the number of gd-17
cells was not evident in SDLNs, and no transcriptional
elevation of IL-17A, IL-17F, or IL-22 was found in the skin
(Supplementary Figure S7c online, data not shown). At this
early age, however, the numbers of migrating DCs including
langerinþ cells were increased in SDLNs of SPT-cKO mice
(Supplementary Figure S7a and b online). This observation
suggests that the migration of LCs from the epidermis precedes
the expansion of gd-17 cells. In the epidermis of SPT-cKO
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Figure 2. Alteration in the structure of lamellar bodies (LB) of SPT-cKO mice
and delay in barrier recovery after tape stripping. (a) Electron micrograph of
LBs. Note globular inclusions instead of lamellar formation within LBs of
granular layer cells from SPT-cKO (cKO) mice at PD14, although those in
newborn SPT-cKO mice show a normal appearance. Microphotographs are
representative LBs from two mice with each genotype. Bar¼50 nm. Postfixed
with RuO4. (b) Delay in recovery from acute barrier disruption in 3-day-old
SPT-cKO mice (black bars, n¼ 23) compared with age-matched control mice
(white bars, n¼20). Graphs show transepidermal water loss (mean±SE) at
the indicated hours after tape stripping. **Po0.01; ***Po0.001. Unpaired
Student’s t-test. (c) Electron micrographs of the epidermis at 6 h after tape
stripping in SPT-cKO mice at PD3 (right panels) and in age-matched wild-type
(WT) mice (left panels). Bottom panels are close-up views. At 6 h after tape
stripping, when the barrier function is restored in WT mice, newly basic
lamellar structures are formed at the stratum granulosum (SG)–stratum
corneum (SC) interface (arrowheads), whereas exocytosis of LBs is still in
progress in cKO mice (black arrows). A convoluted interface and lacunae
(asterisks) at the SG–SC junction are shown, suggesting that lamellar
reorganization is not complete. SG, stratum granulosum. Bars¼200 nm (top
panels), 90 nm (bottom panels). Postfixed with RuO4.
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Figure 3. SPT-cKO mice at 2 weeks of age and older develop psoriasis-like skin lesions. (a) Barrier disruption developed in SPT-cKO mice from 2 weeks of age
and older (solid line, n¼ 8), whereas wild-type (WT) mice retained normal barrier function (dotted line, n¼7). Graphs show transepidermal water loss (mean±SE).
*Po0.05. **Po0.01. Unpaired Student’s t-test. (b) Decreased numbers of lamellar bodies (LBs) per granular cell in SPT-cKO skin. Using electron micrographs of
epidermis postfixed with OsO4, LB numbers were counted within cells at the granular layer of the epidermis in WT mice (white bars, n¼ 5–9) and in SPT-cKO
mice (black bars, n¼ 7–9) at the indicated age. Graphs show LB numbers per cell (mean±SE). *Po0.05. **Po0.01. Unpaired Student’s t-test. (c) SPT-cKO mice at
PD14 showed growth retardation and hair loss (left panel). Skin excoriation and scaly lesions developed in the scalp and face at PD18 (middle panel), and severe
desquamation and generalized erythema were evident at PD21. Representative mice with a typical phenotype are shown. (d) Histological appearance of the dorsal
skins in SPT-cKO (bottom) and WT mice (top) at PD19. Marked hyperkeratosis, acanthosis, dermal cell infiltrates, and capillary proliferation (arrows) were noted in
SPT-cKO mice. Hematoxylin and eosin (H&E) staining; bar¼ 100mm. (e) Altered pattern in K6 expression in the back skin of SPT-cKO mice at PD14. In SPT-cKO
mice, K6 is expressed ectopically in the interfollicular epidermis (arrow) and in the outer root sheath (arrowhead), within which its expression is confined in WT
mice (asterisks). Bar¼ 100mm. (f) Coincident hyperkeratosis in the forestomach epithelia of SPT-cKO mice at PD19 (bottom, asterisk) compared with WT mice
(top). H&E staining. Bar¼ 200mm. (g) Immunostaining with the anti-SPT antibody of the skin of WT and SPT-cKO (cKO) mice at PD18. Although WT mice are
positive for SPT in the epidermis (arrow) and the outer root sheath (arrowhead), SPT-cKO mice are devoid of SPT in the epidermis (arrow) and the outer root sheath
(arrowhead). Right panels are high magnifications of left ones. Asterisk, inflammatory cells. Co-stained with 40,6-diamidino-2-phenylindole. Bars¼ 50mm.
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mice, dendritic epidermal T cells (DETCs) underwent mor-
phological alterations such as a spherical change and a loss of
dendrites (Supplementary Figure S8a online), resembling those
in LCs (Supplementary Figure S6a online). Coincident round-
ing of DETCs and LCs was also observed in mouse epidermis
after TS, implying that barrier damage provokes the initial
events of lymphoid stress surveillance (Strid et al., 2011).
However, gd-17 cells found in SPT-cKO mice were not
derived from DETCs, as they did not express Vg5
(Supplementary Figure S8b online). They are presumably from
dermal gd T cells, which are proinflammatory and mobile
(Gray et al., 2011; Sumaria et al., 2011), and also secrete IL-22
as do Th17 cells (Laggner et al., 2011; Mabuchi et al., 2011).
In SDLNs, SPT-cKO mice showed increased numbers of IL-22-
producing gd T cells compared with WT mice (Figure 5a).
Most gd T cells in SPT-cKO mice produced both IL-17 and
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IL-22, whereas WT mice had a lower percentage of gd T cells
secreting both cytokines (Figure 5b and c). Thus it is likely that
barrier disruption in SPT-cKO mice results in activation and
proliferation of gd T cells that produce both IL-17 and IL-22.
The thickened epidermis of SPT-cKO mice showed activated
Stat3, i.e., they were positive for pY705-Stat3 (Figure 5d),
a characteristic of psoriatic epidermis (Sano et al., 2005,
2008). These data also suggest the contribution of IL-22
secreted from skin-infiltrating gd T cells to acanthosis
through Stat3 activation in keratinocytes (Sa et al., 2007;
Zheng et al., 2007).
Repeated TS fails to generate psoriasis lesions in WT mice
To assess whether chronic barrier insults would produce a
psoriatic phenotype, we performed TS every other day up to
four cycles (five strokes of TS per each cycle) onto the back
skins of WT mice. Interestingly, the TS-induced TEWL eleva-
tion attenuated from the third cycle onward (Supplementary
Figure S9a online). This might be due to constitutive upregula-
tion of enzymes for lipid synthesis in response to repeated
barrier insults. Histologically, repeated TS did not induce
epidermal hyperplasia or detectable inflammation (Supple-
mentary Figure S9b online). Quantitative RT–PCR using the
treated skins did not detect significant gene signatures,
including IL-17A, IL-17F, IL-22, BD3, BD4, and S100A8/9,
all of which were increased in SPT-cKO mice (Supplementary
Figure S9c online). However, K5.Stat3C transgenic mice, in
which keratinocytes express the activation-prone Stat3 (Sano
et al., 2005), showed persistent barrier disruption by TS and
developed psoriasis-like skin lesions where a number of IL-22-
producing cells infiltrated in the dermis (Supplementary
Figure S10 online). These results suggest that persistent barrier
disruption either by ceramide deficiency or the intrinsic signal
abnormality within keratinocytes contributes to the develop-
ment of a psoriasis-like phenotype.
IL-23 stimulation is required for the expansion of cd-17 cells and
psoriasis-like lesions
In the inflamed skin, the upregulation of IL-23p19 and IL-12/
23p40 mRNA transcripts was observed, whereas IL-12p35
mRNA transcripts were unchanged compared with WT mice
(Figure 6a). These data suggest the predominant involvement
of IL-23 over IL-12 in skin lesions of SPT-cKO mice. The
profile tendencies of these genes in SPT-cKO mice are similar
to those in human psoriasis and in K5.Stat3C mice (Nakajima
et al., 2011). Immunostaining of skin lesions displayed an
enriched accumulation of IL-23þCD11cþ cells in the dermis
(Figure 6b). IL-23 stimulates the survival and proliferation of
Th17 cells, and critically participates in the pathogenesis
of psoriasis (Fitch et al., 2007; Nakajima et al., 2011).
Therefore, targeting IL-23 leads to clinical improvement
in psoriatic patients (Nograles and Krueger, 2011). Treatment
of SPT-cKO mice with an anti-IL-12/23p40 antibody
greatly attenuated the skin inflammation and epidermal hyper-
plasia (Figure 6c and d). At the same time, the numbers
of gd-17 cells in SDLNs were decreased (Figure 6e). This
implicates a role for IL-23 in the expansion of disease-
associated gd-17 cells.
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Figure 5. Most cd-17 cells produce IL-22, and thickened epidermis shows
Stat3 activation in SPT-cKO mice. (a) There were increased numbers of IL-22-
producing gd T cells (gd-22) in skin-draining lymph nodes (SDLNs) from SPT-
cKO mice at PD18 (n¼ 4) compared with wild-type (WT) (n¼ 4) mice.
**Po0.01. Unpaired Student’s t-test. (b) Most of the gd T cells produced both
IL-17 and IL-22 in SDLNs from SPT-cKO mice (n¼ 4), whereas a lower %
of them produced both cytokines in WT mice (n¼4). Symbols show mean %
of gd-17/22 cells within gd T cells. **Po0.01. Unpaired Student’s t-test.
(c) Representative flow cytometric data of SDLN cells gated on gd T cells.
(d) Immunohistochemical staining with anti-phosphorylated (pY) Stat3 (Y705)
of WT and SPT-cKO mice at PD18. Representative micrographs are shown
from three independent experiments. The thickened epidermis of SPT-cKO
mice showed pY-Stat3 in epidermal cells, in particular at the basal layer,
whereas no pY-Stat3 was detected in the epidermis of WT mice. Dotted lines,
epidermis. Bar¼ 50mm.
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DISCUSSION
Epithelial-specific genes have been identified as candidates of
psoriasis susceptibility, including corneodesmosin (CDSN)
gene (Orru et al., 2005), the b-defensin cluster (Hollox
et al., 2008), and late cornified envelope (LCE) 3B and 3C
genes (LCE3C_LCE3B-del) (de Cid et al., 2009). Barrier
dysfunction is a putative contribution of these genes in
psoriasis (Roberson and Bowcock, 2010). This view may
change the paradigm of the etiology of psoriasis, like AD in
which loss-of-mutation of FLG was identified (Palmer et al.,
2006).
Ceramides in the SC are essential for barrier homeostasis,
and its downside has been observed in lesional skin of
psoriasis, as well as AD (Melnik et al., 1988; Holleran et al.,
1991; Imokawa et al., 1991; Motta et al., 1993, 1994;
Alessandrini et al., 2004). SPT expression was reported to be
significantly reduced in psoriatic lesions compared with
psoriatic uninvolved skins and inversely correlated with
Psoriasis Area Severity Index (PASI) score (Hong et al.,
2007). In another study, alterations of sphingomyelidase
levels were observed in psoriatic lesions (Alessandrini et al.,
2004). Therefore, ceramide deficiency and resulting barrier
disruption may be crucial for the development of psoriasis
(Wolf et al., 2012).
In the present study, newly established keratinocyte-specific
SPT-cKO mice have suggested the profound interactions
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Figure 6. Involvement of IL-23 in the generation of skin lesions in SPT-cKO mice. (a) Upregulated mRNA transcript levels of IL-23 in skin lesions of SPT-cKO mice
at PD18 (n¼ 5) compared with skins of wild-type (WT) mice (n¼ 5). Symbols show mean mRNA transcript levels. *Po0.05. ns, not significant. Unpaired Student’s
t-test. (b) Accumulation of IL-23þCD11cþ cells in the dermis of skin lesions of SPT-cKO mice at PD18. Immunostaining with anti-IL-23p19 (red) and anti-CD11c
(green) antibodies. Bottom panel shows a high magnification view of the rectangular area in the top panel. Note that the epidermis also expresses IL-23p19.
Bar¼50mm. (c) Intraperitoneal administration of anti-IL-12/23p40 antibody to SPT-cKO mice attenuated the skin lesions (hematoxylin and eosin). Bar¼ 100mm.
Representative histology is shown from three independent experiments. (d) Attenuation of epidermal hyperplasia by anti-IL-12/23p40 treatment. Bars show
epidermal thickness (mean mm±SD) of skin lesions of SPT-cKO mice treated with control IgG (n¼3) or with anti-IL-12/23p40 (n¼6). *Po0.05. Unpaired
Student’s t-test. (e) Decline in numbers of gd-17 cells in skin-draining lymph nodes after treatment with anti-IL-12/23p40 compared with those treated with IgG
control. Representative data are shown from three independent experiments.
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between barrier dysfunction and immunological alterations
that lead to psoriasis phenotype. Repeated barrier insults by
TS did not upregulate psoriasis-associated gene expressions
or produce psoriasis-like lesions in WT mice. This result
suggests that ceramide deficiency, but not barrier abnormality
alone, contributes to the development of a psoriatic pheno-
type in SPT-cKO mice. However, it should be noted that
psoriasis-like inflammation could be induced by chronic
barrier disruption due to essential fatty acid deficiency
(Wood et al., 1994, 1997; Jansen et al., 2002). K5.Stat3C
mice, which represent psoriasis model mice (Sano et al.,
2005), showed persistent barrier disruption by TS and at the
same time developed psoriasis-like lesions with a number
of IL-22-producing T cells in the dermis, similar to SPT-cKO
mice. As ceramide deficiency led to psoriasis-like lesions,
topical ceramides may improve barrier function, the
immunological abnormalities, and psoriatic skin phenotype.
As gd-17 cells are not derived from DETCs, we assume
that they are dermal gd T cells, which are thought to
be a major subset of IL-17-precommitted cells in mouse skin
(Gray et al., 2011), and play a role in the innate immunity
against infection and in development of the psoriasis-like
dermatitis (Mabuchi et al., 2011). The importance of IL-23 is
supported by data showing that IL-23p19 and IL-12/23p40
mRNA levels were increased in the lesions, and the treatment
with anti-IL-12/23 antibody reduced gd-17 cells numbers
and attenuated lesions. In intradermal IL-23 treatment or
topical imiquimod treatment models, gd-17 cells were
associated with psoriasis-like phenotype (Cai et al., 2011;
Mabuchi et al., 2011). Imiquimod-induced skin inflamma-
tion and epidermal hyperplasia were significantly attenuated
in Tcrd / mice (Cai et al., 2011). In psoriasis patients, both
Th17 cells and gd-17 cells were found to be the IL-23-respon-
sive IL-17 producers (Cai et al., 2011; Laggner et al., 2011).
The causal relationship between the epidermal dysfunction
and immunological abnormalites including LCs, gd-17 cells,
and Th17 cells needs to be clarified to understand the
pathogenesis of psoriasis.
MATERIALS AND METHODS
Mice
All animal studies were approved by Institutional Animal Care and
Use Committees at Osaka University and Kochi University. Cre-
mediated sptlc2 gene–targeted mice were generated by crossing
floxed sptlc2 mice (Ohta et al., 2009) with K5-Cre transgenic mice
(Tarutani et al., 1997).
Patients and normal controls
The study protocol was conducted in accordance with the guidelines
of the World Medical Association’s Declaration of Helsinki and was
approved by the Institute Ethical Review Board of the Kochi Medical
School, Kochi University. Nine patients with chronic, plaque-type
psoriasis (6 male and 3 female individuals) were recruited from the
Department of Dermatology, Kochi Medical School Hospital in
Nankoku, Kochi, Japan. Normal control skin was obtained from
nine healthy volunteers (five male and four female individuals).
We obtained written informed consents from all the patients and
healthy volunteers.
In vivo administration of antibodies
Details of anti-IL-12/23p40 (CNTO 3913) and control IgG (CNTO
1322) were described (Nakajima et al., 2011). Antibodies at a dose of
300mg per mouse were administered intraperitoneally at PD6. Skin
and SDLN node cells were sampled at PD18.
Immunohistochemical staining
Antibodies used included: anti-ceramides (ENZO Life Science,
Farmingdale, NY), anti-CD3e (Santa Cruz Biotechnology, Santa Cruz,
CA), anti-IL-23p19 (ab45420, Abcam, Cambridge, England), anti-IL-
22 (Novus Biologicals, Littleton, CO), anti-CD11c (BioLegend, San
Diego, CA), anti-CD207 (eBioscience, San Diego, CA), anti-TCR gd
(Santa Cruz Biotechnology), anti-Gr-1 (R&D systems, Minneapolis,
MN), anti-SPT (Abcam), anti-keratin 1, 5, 6, involucrin, filaggrin, and
loricrin (Covance, Princeton, NJ). Staining was performed on either
formalin-fixed paraffin-embedded, snap-frozen sections, or epidermal
sheets using relevant secondary antibodies as described (Nakajima
et al., 2011).
Flow cytometric analysis
All the antibodies used were conjugated with fluorochrome.
Intracellular staining with anti-IL-17 (BioLegend) and anti-IL-22
(R&D Systems) was performed as described (Nakajima et al., 2011).
To identify DETCs, anti-Vg5 (BD Pharmingen, San Diego, CA) and
anti-TCR-gd (BioLegend) were used. Langerinþ cells were stained
with anti-CD40 and CD11c (BD Pharmingen), followed by
permeabilization, and treated with biotin-labeled anti-CD207
(eBioscience) and FITC-streptavidin (BD Pharmingen). Cells were
analyzed using a FACSCalibur (BD Biosciences, San Jose, CA)
or a JSAN (Bay Bioscience, Kobe, Japan) and were then analyzed
with CellQuest Pro software (BD Biosciences) or FlowJo software
(Treestar, Ashland, OR).
Imaging mass spectrometric (IMS) analyses
The protocol of IMS was previously described elsewhere (Goto-Inoue
et al., 2012).
Determination of TEWL and SC hydration
To evaluate TEWL, we used a Tewameter (TEWAMETER TM300,
Courage & Khazaka, Cologne, Germany) from six separate sites
per mouse. For analyses of SC hydration, a skin-surface hygrometer
(Skicon-200, IBS, Hamamatsu, Japan) was used. The measurements
were repeated at least six times to obtain averages.
Electron microscopy
Mouse skins were fixed overnight in cacodylate-buffered 2.0%
glutaraldehyde and then post-fixed in both 1% aqueous osmium
tetroxide (OsO4) and 0.5% aqueous ruthenium tetroxide (RuO4)
containing 0.25% potassium ferrocyanide, then embedded in Quetol
812. Thin sections were stained with uranyl acetate and lead citrate
and examined with a JEOL JEM-1010 transmission electron micro-
scope (JEOL, Tokyo, Japan) in transmission mode at 80 kV.
Quantitative (q) RT–PCR
Dorsal skin and SDLN cells from mice were minced with scissors into
small pieces on ice, and were then disrupted by ultrasonic sonication.
Extraction of RNA and qRT–PCR were performed as described
(Nakajima et al., 2011).
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Statistical analysis
All samples were compared with two-tailed, unpaired Student’s t-test,
Wilcoxon t-test, or Mann–Whitney U-test as indicated. P-values less
than 0.05 are considered significant.
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